Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

GENB

Generate Biomedicines Inc

May 29 • 04:00PM ET

13.12

+0.03 0.23 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: KYMR RYTM APGE NUVL BMRN INCY KRYS VKTX AXSM NBIX

| Held by: ARKG VTI ONEQ VXF GNMX

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-	Insider Own	57.39%	Shs Outstand	128.19M	Perf Week	-6.15%
Market Cap	1.68B	Forward P/E	-	EPS next Y	-2.15	Insider Trans	14.65%	Shs Float	54.63M	Perf Month	5.98%
Enterprise Value	1.23B	PEG	-	EPS next Q	-0.51	Inst Own	19.40%	Short Float	6.32%	Perf Quarter	3.72%
Income	-	P/S	-	EPS this Y	50.83%	Inst Trans	37.99%	Short Ratio	6.49	Perf Half Y	-
Sales	-	P/B	3.27	EPS next Y	4.03%	ROA	-	Short Interest	3.45M	Perf YTD	3.72%
Book/sh	4.02	P/C	3.26	EPS next 5Y	27.56%	ROE	-	52W High	16.75 -21.66%	Perf Year	-
Cash/sh	4.03	P/FCF	-	EPS past 3/5Y	- -	ROIC	-	52W Low	11.00 19.27%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	7.47% 9.31%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-	Oper. Margin	-	ATR (14)	1.19	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	9.17	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	47.12	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	9.17	EPS Q/Q	-	SMA20	-7.18%	Beta	-	Target Price	25.40
Payout	-	Debt/Eq	0.13	Sales Q/Q	-	SMA50	0.23%	Rel Volume	0.83	Prev Close	13.09
Employees	312	LT Debt/Eq	0.10	Earnings	May 07 BMO	SMA200	1.65%	Avg Volume	531.83K	Price	13.12
IPO	Feb 27, 2026	Option/Short	No / Yes	EPS/Sales Surpr.	-110.63% 36.83%	Trades		Volume	440,758	Change	0.23%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)